Normobaric Hyperoxia Combined With Endovascular Treatment in Acute Ischemic Stroke (OPENS-2)

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 282 participants.

Also called NCT04681651

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 282 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04681651
Other papers using this trial's data
  • Normobaric hyperoxia combined with endovascular treatment for acute ischaemic stroke in China (OPENS-2 trial): a multicentre, randomised, single-blind, sham-controlled trial Lancet (London, England), 2025-02-08 DOI, PubMed 39922675

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04681651. Randomized; triple masking; primary purpose treatment. Start 2021-04-22 (actual); primary completion 2023-05-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Normobaric Hyperoxia Combined With Endovascular Treatment in Acute Ischemic Stroke (OPENS-2)
Condition
Stroke, Acute
Condition
Neuroprotection
Intervention (Drug)
Normobaric Hyperoxia
Intervention (Drug)
Sham Normobaric Hyperoxia
Intervention (Procedure)
Endovascular Thrombectomy
Lead sponsor
Capital Medical University (class: other)
Collaborator
Tianjin Huanhu Hospital (class: other)
Collaborator
Shengli Oilfield Hospital (class: other)
Collaborator
Beijing Fengtai You'anmen Hospital (class: not stated)
Collaborator
Jiujiang University Affiliated Hospital (class: other government)
Collaborator
Zhangzhou Municipal Hospital of Fujian Province (class: other)
Collaborator
Baotou Central Hospital (class: other)
Collaborator
Luoyang Central Hospital (class: other)
Collaborator
Nanyang Central Hospital (class: other)
Collaborator
Qingdao Central Hospital (class: other)
Collaborator
The Third People's Hospital of Jinan (class: not stated)
Collaborator
Rizhao People's Hospital (class: other)
Collaborator
Anyang People's Hospital (class: not stated)
Collaborator
Shanghai 10th People's Hospital (class: other)
Collaborator
Dalian Municipal Central Hospital (class: other)
Collaborator
Zhoukou Central Hospital (class: other)
Collaborator
Nanyang Nanshi Hospital (class: other)
Collaborator
Nanning Second People's Hospital (class: other)
Collaborator
Zhumadian Central Hospital (class: other)
Collaborator
Taizhou Hospital (class: other)
Collaborator
Second Affiliated Hospital of Nanchang University (class: other)

Registry records

Assembled by a program from ROR and ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.

Registry organizations 11

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 33 trials in this atlas.

    Organization013xs5b60

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 6 trials in this atlas.

    Organization

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 5 trials in this atlas.

    Organization

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 6 trials in this atlas.

    Organization

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

    Organization

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 22 trials in this atlas.

    Organization01nxv5c88

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 17 trials in this atlas.

    Organization

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

    Organization

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.

    Organization

  • An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.

    Organization00q6wbs64

Record details

Record id
cardio:ct-nct04681651
Content hash
f7e1819ef3cc9c467bc0ea572c0e2cffbdcc21ca826c17c19123d0a79b8fc181